Gangnam Severance Hospital: Breast Neoplasms trials

The registry lists 17 Breast Neoplasms studies with Gangnam Severance Hospital as lead sponsor. 10 are open to participants now and 0 have results posted.

Phase 2 5Phase 3 1Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Endocrine Therapy Base on 21-gene RSNot yet recruitingNCT07311122
• Additional Prognostic Value of Tumor Grade Beyond the 21-gene Recurrence ScoreNot yet recruitingNCT07093775
• Immune-checkpoint Blockade After Partial Breast Irradiation by Pembrolizumab in Early TNBCNot yet recruitingNCT07011823Phase 2
• Necessity of Post-mastectomy Radiotherapy After Neoadjuvant Chemotherapy and MastectomyNot yet recruitingNCT05993559Phase 3
• OFS in Premenopausal Node+ Breast Cancer With Low Genomic RiskRecruitingNCT05333328Phase 4
• A Study to Reduce Persistent Post-mastectomy Pain Using Opioid-free AnesthesiaRecruitingNCT05146778Not applicable
• Phase II Trial of Anti-HER2 Treatment in HER2-enriched Early Breast Cancer Identified by PAM50 (HER2E-PAM, PAMILIA Study)RecruitingNCT04817540Phase 2
• Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor RecurrenceRecruitingNCT04741737Not applicable
• Primary Surgical Prevention of Breast Cancer-related LymphedemaRecruitingNCT04687956Not applicable
• Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast CancerRecruitingNCT03750396Phase 2
• Axillary Nodal Burden in HER2+ and TNBCCompletedNCT07211451
• SURPASS Retrospective StudyCompletedNCT05779982
• Effects of Mediterranean Diet Based Intervention in Breast Cancer PatientsStatus unknownNCT04045392Not applicable
• Effects of Mediterranean Diet and Naltrexone/Bupropion Treatment in Obese Breast Cancer PatientsCompletedNCT03581630Not applicable
• Neoadjuvant Trastuzumab and Letrozole for Postmenopausal WomenStatus unknownNCT02214004Phase 2
• Intraoperative Radiotherapy for Korean Patients With Breast CancerStatus unknownNCT02213991Phase 2
• Validity of Sentinel Lymphnode Biopsy After Neoadjuvant Chemotherapy Cancer Patients With Radiologically Positive Axillary Lymph NodesCompletedNCT01622478